"Professor Calais, when is the world's first cardiac surgery based on STAR stem cell technology going to begin?"

When a reporter was given the opportunity to ask questions, he eagerly asked about heart surgery.

"We at Sumitomo Pharmaceutical and the Institute of Physics and Chemistry at Imperial Naito University have had an in-depth discussion with Professor Takuya Uchimura of Tokyo Chuo Hospital. So far, suitable clinical trial patients have also been found. This time, Dr. Takuya Uchimura will use a cardiac artery patch cultivated by the Institute of Physics and Chemistry at Imperial Naito University to treat the aortic arch and ascending aorta of patients who have become necrotic. In the past, this was an extremely complex and difficult operation, which often required the replacement of the ascending aorta and aortic arch for the patient, and Professor Uchimura is one of the best cardiac surgeons in Japan......

"This is because the patient was treated with a cardiac artery patch. Therefore, the difficulty of the operation will be greatly reduced. Professor Uchimura now only needs to attach this heart artery patch to the patient's necrotic ascending aorta and aortic arch part, and the healthy arterial wall cells on the patch will automatically repair the damaged cells, thus achieving the goal of curing the patient......

"Hahaha......"

As Shiori Tokunaga explained the differences of the surgery in an easy-to-understand manner at the venue, there was a burst of happy laughter in the venue. And the reporters present were also obviously very interested in this miraculous heart artery patch. You know, anyone who knows a little about heart diseases will understand that myocardial tissue is a cell tissue that cannot be regenerated and cannot be repaired once damaged, but now, the team led by Professor Hideki Calais has solved this problem in the medical field. Cell-level transplantation using regenerative medicine has simplified previously complex surgeries. More importantly, this cell-level transplant has more curative effects and fewer side effects than traditional surgery.

When Shiori Tokunaga briefly explained the general plan of the STAR stem cell interventional heart surgery for the reporters present, the enthusiasm of the reporters on the scene also rose. Looking from the podium, I saw that the audience was full of reporters who raised their hands to ask questions. Compared to the last retinal transplant press conference, this time it was even more enthusiastic.

"That gentleman over there, may I ask...... Do you have anything to ask?"

"Hey, Professor Calais, there were rumors that Sumitomo Pharma would work with your team to establish a regenerative medicine company based on STAR stem cell technology, may I ask...... Is this rumor true?"

Hearing that this reporter actually asked Professor Calais directly, Tokunaga Shiori naturally did not want to answer on his behalf. So Kalai Hideki turned on the microphone in front of him, and then replied to the reporter with a somewhat serious expression:

"Sumitomo Pharmaceutical, in fact, has been talking to me about the establishment of a company for a long time...... But...... Because of the rigorous attitude of researchers, I had always had a hard time making up my mind. It wasn't until after the last retinal transplant was declared successful that I began to realize that maybe we were a little too conservative. ”

"Theoretically, STAR stem cells can differentiate into any tissue in the human body, which means that once this technology is promoted, any tissue and organ in the human body will have the ability to regenerate. Personally, I believe that this technology is of great significance for our country, which has entered an aging population. And this technology will also revolutionize many treatments in modern medicine. For example, if we use STAR stem cell technology to restore the function of the patient's pancreatic islets, we can completely cure the diabetes completely, if we use STAR stem cell technology to restore the function of the patient's pancreas.

"It is precisely to make this day a reality as soon as possible, so ...... We need more money and talent to invest in the research of STAR stem cells, and on the other hand, I think we also have an obligation to make some mature technologies available in clinical practice as soon as possible. For example, the cardiac artery patch used in this surgery is a very effective alternative to cardiac surgery. In order to make these similar excellent technologies not confined to the laboratory, I think ...... I can accept the use of commercial means to better promote this technology, so as to bring good news to more patients, and this is what I, a researcher of regenerative medicine, really want to say......"

Hearing Professor Calais's sincere speech, there was a round of applause in the venue. Immediately afterwards, many reporters asked about the research on STAR stem cells. As a representative of Sumitomo Pharmaceutical, Shiori Tokunaga also answered some related questions one by one.

"Professor Calais, it is said that you have become a strong contender for the Nobel Prize in Medicine this year, have you ever looked forward to this year's Nobel Prize?"

"I haven't actually thought about this at all, maybe I feel more fulfilled than the Nobel Prize to be able to use STAR stem cell technology to bring health to more patients struggling with diseases!"

……

After the press conference, Hideki Kalai and Takuya Uchimura, a cardiac surgeon in charge of the clinical trial, exchanged pleasantries for a while, and then couldn't wait to leave. At this moment, Shiori Tokunaga suddenly stopped Professor Calais, and then pulled him aside and asked him carefully:

"Professor...... Have you found a solution to Hikozaburo Ueno's matter, Dean Saito has been asking about the progress of your side!"

"Oh...... That one...... I'm still trying to find a solution, but the immune system problem is complicated, so ...... For a while, I couldn't come up with a perfect solution. But...... I believe that as soon as the new company is established, I will be able to free up my hands, and I will definitely think of a safe treatment plan when the time comes. By the way, how about the regimen of letting the patient take immunosuppressants, and whether the patient's symptoms have been alleviated!"

"This ...... I've heard that there are still some effects, but this is only a palliative and not a cure, and if this continues, Mr. Hikozaburo's body will not be able to bear it......"

"Isn't this a common situation in patients who have undergone transplant surgery, and there are not a few transplant patients who have been taking immunosuppressants for a long time in order to prolong their lives. So...... Let's wait and see!"

https:

Genius one second to remember the address of this site:. Mobile version reading URL: m.